Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2024 | Establishing the North American Prodromal Synucleinopathy (NAPS) consortium

Aleksandar Videnovic, MD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, talks on the establishment of the North American Prodromal Synucleinopathy (NAPS) consortium. The goals of the consortium are two-fold: to recruit patients with REM sleep behavior disorder (RBD) for a longitudinal natural history study centered on biomarker discovery and to develop a cohort-ready population who can be enrolled in disease modifying therapy trials when they launch. This interview took place at the American Academy of Neurology (AAN) Annual Meeting 2024 in Denver, CO.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.